AtheroTalk: Michael Shapiro
This time, we interview Prof. Michael Shapiro, President of the American Association of Preventive Cardiology and Chair-Elect of the AHA Council on Lipidology, Lipoprotein, Metabolism…
Author: Mateusz Szwachta
Stronger Together: Uniting Heart and Stroke Awareness in Europe
Brussels, 29 September 2025 — The European Alliance for Cardiovascular Health (EACH) is bringing together World Heart Day (29 September) and World Stroke Day (29…
AtheroTalk: EAS Paediatric Lipid Working Group
Tune in to this special FH Awareness Week episode of our podcast featuring Prof. Steve Humphries. In this conversation, he shares valuable insights into familial…
AtheroTalk: EAS Consensus Statement on Systemic Metabolic Disorders
Rates of obesity and related metabolic disorders have risen dramatically worldwide, yet most treatment strategies still focus on individual conditions, missing the bigger picture. A…
EAS Newsletter September 4, 2025
Publications: 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias We are pleased to announce that the European Society of Cardiology…
Featured Open Lecture: September-October 2025
The Anitschkow Lecture: Beyond LDL: inflammation screening and inflammation inhibition for atherosclerotic disease by Prof. Paul Ridker We are pleased to present the 2025 Anitschkow…
New editorial: 2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidemias – Advancing evidence-based care through innovation
The 2025 Focused Update of the ESC/EAS Guidelines for the management of dyslipidemias, now published jointly in Atherosclerosis [1] and the European Heart Journal, signifies further evolution…
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
We are pleased to announce that the European Society of Cardiology (ESC), together with the European Atherosclerosis Society (EAS), has published the 2025 Focused Update…
EAS Newsletter July 22, 2025
Publications: The essential role of sex and gender in atherosclerosis research This important editorial represents a joint statement from the Editorial Board of Atherosclerosis and the…
AtheroTalk: Simon Pfisterer
In this episode, our guest is Dr Simon Pfisterer, group leader at the University of Helsinki and Chief Scientific Officer of Moncyte Ltd. His work…